Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 232

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A Molecular Classification of Papillary Renal Cell Carcinoma

Open access
Yang, Ximing J., Tan, Min-Han, Kim, Hyung L., Ditlev, Jonathon A., Betten, Mark W., Png, Carolina E., Kort, Eric J., Futami, Kunihiko, Furge, Kyle A., Takahashi, Masayuki, Kanayama, Hiro-omi, Tan, Puay Hoon, Teh, Bin Sing, Luan, Chunyan, Wang, Kim, Pins, Michael, Tretiakova, Maria, Anema, John, Kahnoski, Richard, Nicol, Theresa, Stadler, Walter, Vogelzang, Nicholas G., Amato, Robert, Seligson, David, Figlin, Robert, Belldegrun, Arie, Rogers, Craig G., Teh, Bin Tean·2005·Cancer Research

Abstract

Despite the moderate incidence of papillary renal cell carcinoma (PRCC), there is a disproportionately limited understanding of its underlying genetic programs. There is no effective therapy for metastatic PRCC, and patients are often excluded from kidney cancer trials. A morphologic classification of PRCC into type 1 and 2 tumors has been recently proposed, but its biological relevance remains uncertain. We studied the gene expression profiles of 34 cases of PRCC using Affymetrix HGU133 Plus 2.0 arrays (54,675 probe sets) using both unsupervised and supervised analyses. Comparative genomic microarray analysis was used to infer cytogenetic aberrations, and pathways were ranked with a curated database. Expression of selected genes was validated by immunohistochemistry in 34 samples with 15 independent tumors. We identified two highly distinct molecular PRCC subclasses with morphologic correlation. The first class, with excellent survival, corresponded to three histologic subtypes: type 1, low-grade type 2, and mixed type 1/low-grade type 2 tumors. The second class, with poor survival, corresponded to high-grade type 2 tumors (n = 11). Dysregulation of G1-S and G2-M checkpoint genes were found in class 1 and 2 tumors, respectively, alongside characteristic chromosomal aberrations. We identified a seven-transcript predictor that classified samples on cross-validation with 97% accuracy. Immunohistochemistry confirmed high expression of cytokeratin 7 in class 1 tumors and of topoisomerase IIα in class 2 tumors. We report two molecular subclasses of PRCC, which are biologically and clinically distinct and may be readily distinguished in a clinical setting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-05-0533

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 232

Metadata

Authors
Yang, X. J., Tan, M.-H., Kim, H. L., Ditlev, J. A., Betten, M. W., Png, C. E., Kort, E. J., Futami, K., Furge, K. A., Takahashi, M., Kanayama, H.-O., Tan, P. H., Teh, B. S., Luan, C., Wang, K., Pins, M., Tretiakova, M., Anema, J., Kahnoski, R., Nicol, T., Stadler, W., Vogelzang, N. G., Amato, R., Seligson, D., Figlin, R., Belldegrun, A., Rogers, C. G., & Teh, B. T.
Venue
Cancer Research
Published
2005-07-01
Volume
65
Issue
13
Pages
5628-5637
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2132125330
Cited by
232
References
2
FWCI
13.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Molecular Classification of Papillary Renal Cell Carcinoma. https://app.cochat.ai/papers/10.1158/0008-5472.can-05-0533
The paper
Yang, X. J., Tan, M.-H., Kim, H. L., Ditlev, J. A., Betten, M. W., Png, C. E., Kort, E. J., Futami, K., Furge, K. A., Takahashi, M., Kanayama, H.-O., Tan, P. H., Teh, B. S., Luan, C., Wang, K., Pins, M., Tretiakova, M., Anema, J., Kahnoski, R., . . . Teh, B. T. (2005). A Molecular Classification of Papillary Renal Cell Carcinoma. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-0533

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.